MedPath

MINT-ATENOL

MINT-ATENOL

Approved
DIN Number

02368048

Drug Class

Human

Market Date

Jun 13, 2011

Company
HC

mint pharmaceuticals inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02368048
AIG Number0113847001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C07AB03 ATENOLOL
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification24:24.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ATENOLOLActive
Strength: 100 MG
Monograph: ATENOLOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.